These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25940406)

  • 21. [Imaging subcutaneous atrophy in circumscribed scleroderma with 20 MHz B-scan ultrasound].
    Lévy JJ; Gassmüller J; Audring H; Brenke A; Albrecht-Nebe H
    Hautarzt; 1993 Jul; 44(7):446-51. PubMed ID: 8365879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib treatment of generalized localized scleroderma (morphea).
    Moinzadeh P; Krieg T; Hunzelmann N
    J Am Acad Dermatol; 2010 Nov; 63(5):e102-4. PubMed ID: 20950732
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial localised scleroderma from Bangladesh: two case reports.
    Wadud MA; Bose BK; Al Nasir T
    Bangladesh Med Res Counc Bull; 1989 Jun; 15(1):15-9. PubMed ID: 2818409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic compression by sclerotic patches of morphea: an original mechanism of lymphedema in a child.
    Samimi M; Maruani A; Machet MC; Baulieu F; Machet L; Lorette G
    Pediatr Dermatol; 2010; 27(1):58-61. PubMed ID: 20199412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of epidermal atrophy in localized scleroderma (morphea).
    Serup J
    Dermatologica; 1986; 172(4):205-8. PubMed ID: 3519301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the efficacy and safety of topical imiquimod 5% for plaque-type morphea: a multicenter, prospective, vehicle-controlled trial.
    Dytoc M; Wat H; Cheung-Lee M; Sawyer D; Ackerman T; Fiorillo L
    J Cutan Med Surg; 2015; 19(2):132-9. PubMed ID: 25775634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphea After Liposuction Ultrasonography.
    Araneda-Ortega P; Poblete-Villacorta MJ; Muñoz-López C; Vera-Kellet C; Wortsman X
    J Ultrasound Med; 2022 Oct; 41(10):2629-2635. PubMed ID: 35023212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An extended high-frequency ultrasound protocol for assessing and quantifying of inflammation and fibrosis in localized scleroderma.
    Ranosz-Janicka I; Lis-Święty A; Skrzypek-Salamon A; Brzezińska-Wcisło L
    Skin Res Technol; 2019 May; 25(3):359-366. PubMed ID: 30638285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Color Doppler Ultrasound Assessment of Subclinical Activity With Scoring of Morphea.
    Parra-Cares J; Wortsman X; Alfaro-Sepúlveda D; Mellado-Francisco G; Ramírez-Cornejo C; Vera-Kellet C
    J Cutan Med Surg; 2023; 27(5):454-460. PubMed ID: 37533149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solitary Plaque-type Morphea with Dystrophic Calcinosis Cutis.
    Deza G; Sánchez-Schmidt JM; Pujol RM
    Acta Derm Venereol; 2016 Mar; 96(3):418-9. PubMed ID: 26525184
    [No Abstract]   [Full Text] [Related]  

  • 33. Ultrasound Morphea Activity Scoring (US-MAS): Modified US-MAS.
    Wortsman X; Vera-Kellet C
    J Ultrasound Med; 2023 Oct; 42(10):2447-2450. PubMed ID: 37129178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of Using Elastography Ultrasound in Pediatric Localized Scleroderma (Morphea).
    Pérez M; Zuccaro J; Mohanta A; Tijerin M; Laxer R; Pope E; Doria AS
    Ultrasound Med Biol; 2020 Dec; 46(12):3218-3227. PubMed ID: 32951932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition of the eccrine glands is involved in skin fibrosis in morphea.
    Takahashi M; Akamatsu H; Yagami A; Hasegawa S; Ohgo S; Abe M; Iwata Y; Arima M; Mizutani H; Nakata S; Matsunaga K
    J Dermatol; 2013 Sep; 40(9):720-5. PubMed ID: 23855882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disabling pansclerotic morphea of children.
    Diaz-Perez JL; Connolly SM; Winkelmann RK
    Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on morphea: part II. Outcome measures and treatment.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):231-42; quiz 243-4. PubMed ID: 21238824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
    Johnson W; Jacobe H
    J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI findings in deep and generalized morphea (localized scleroderma).
    Horger M; Fierlbeck G; Kuemmerle-Deschner J; Tzaribachev N; Wehrmann M; Claussen CD; Fritz J
    AJR Am J Roentgenol; 2008 Jan; 190(1):32-9. PubMed ID: 18094291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of penicillin G on corium thickness in linear morphea of childhood: An analysis using ultrasound technique.
    Möhrenschlager M; Jung C; Ring J; Abeck D
    Pediatr Dermatol; 1999; 16(4):314-6. PubMed ID: 10469421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.